Up to three daily servings of kimchi may lower men's obesity risk
- Details
- Category: Research
Eating up to three daily servings of the Korean classic, kimchi, may lower men's overall risk of obesity, while radish kimchi is linked to a lower prevalence of midriff bulge in both sexes, finds research published in the open access journal BMJ Open.
Kimchi is made by salting and fermenting vegetables with various flavourings and seasonings, such as onion, garlic, and fish sauce.
New technology makes cancer easier for immune system to find and destroy
- Details
- Category: Research
A new technology to increase visibility of cancer cells to the immune system using CRISPR has been developed, and could lead to a new way to treat cancer.
Major histocompatibility complex (MHC) class I molecules are an immune complex present on the surface of all cells in humans. MHC class I molecules are a prerequisite for the immune system to recognize and eliminate cancer.
'Cancer-cooling' protein puts bowel cancer on ice
- Details
- Category: Research
A protein in the immune system can be manipulated to help overcome bowel cancer, according to new research from The Australian National University (ANU).
Bowel cancer claims more than 100 lives in Australia each week, yet around 90 per cent of cases can be successfully treated if detected early.
Autonomous synthesis robot uses AI to speed up chemical discovery
- Details
- Category: Research
Chemists of the University of Amsterdam (UvA) have developed an autonomous chemical synthesis robot with an integrated AI-driven machine learning unit. Dubbed 'RoboChem', the benchtop device can outperform a human chemist in terms of speed and accuracy while also displaying a high level of ingenuity. As the first of its kind, it could significantly accelerate chemical discovery of molecules for pharmaceutical and many other applications.
Could two drugs be better than one for treating prostate cancer?
- Details
- Category: Research
Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug, a multi-institution, Phase 3 clinical trial led by UC San Francisco researchers has found.
The approach can extend the time between debilitating drug treatments without prolonging the time it takes to recover from each treatment.
New medicine can create a new life for diabetes patients - without needles
- Details
- Category: Research
There are approximately 425 million people worldwide with diabetes. Approximately 75 million of these inject themselves with insulin daily. Now they may soon have a new alternative to syringes or insulin pumps. Scientists have found a new way to supply the body with smart insulin.
The new insulin can be eaten by taking a capsule or even better, within a piece chocolate.
Complement system causes cell damage in Long COVID
- Details
- Category: Research
Most people infected with the SARS-CoV-2 virus recover after the acute illness. However, a significant proportion of infected individuals develop long-lasting symptoms with a wide range of manifestations. The causes and disease mechanisms of Long COVID are still unknown, and there are no diagnostic tests or targeted treatments.
More Pharma News ...
- Molecular 'super-glue' shows promise of cancer drug discovery platform
- Accelerating how new drugs are made with machine learning
- mRNA technology could be possible treatment for rare diseases
- Smart skin bacteria are able to secrete and produce molecules to treat acne
- Creating novel amino acid nanoparticles with enhanced anticancer activity
- Major breakthrough unveils immune system's guardian: IKAROS
- Healthy omega-3 fats may slow deadly pulmonary fibrosis